MARKET

DNPUF

DNPUF

DAI Nippon Pharm
OTCPK
10.50
NaN%
Opening 09:30 05/21 EDT
OPEN
--
PREV CLOSE
10.50
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
19.20
52 WEEK LOW
6.34
MARKET CAP
4.71B
P/E (TTM)
6.20
1D
5D
1M
3M
1Y
5Y
1D
Sumitomo Pharma Co., Ltd. GAAP EPS of ¥268.99, revenue of ¥453.29B
Seeking Alpha · 05/13 17:41
Sumitomo Pharma Profit Surges on Higher Revenue and Cost Controls
TipRanks · 05/13 04:33
Sumitomo Pharma Issues Cautious FY2025 Results Conference Materials
TipRanks · 05/13 04:33
Sumitomo Pharma Ends Major Equity Offering, Withdraws Share Issuance Shelf
TipRanks · 04/27 02:52
Sumitomo Pharma Sets Terms for Over ¥100 Billion Equity Offering
TipRanks · 04/20 08:53
Sumitomo Pharma Refinances Guaranteed Debt With New Bridge Loan
TipRanks · 04/08 07:37
Sumitomo Pharma Launches Major Share Offering to Strengthen Financial Base
TipRanks · 04/08 07:37
Sumitomo Pharma to Book ¥48.3 Billion Dividend as Non-Operating Income With No Group Profit Impact
TipRanks · 03/25 07:02
More
About DNPUF
Sumitomo Pharma Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through three geographical segments. The Japan segment is engaged in the manufacture, purchase, and sale of prescription drugs, purchase and sale of medical devices, undertakes development and manufacture in the field of regenerative medicine and cellular medicine, and the manufacture of pharmaceuticals, medical devices, and regenerative medicine products that have been developed through joint development in the field of regenerative medicine. This segment also provides storage and delivery service of pharmaceuticals. The North America segment is engaged in the manufacture, purchase, and sale of prescription drugs. The Asia segment is engaged in the manufacture and sale of prescription drugs (small packaging), and the import, purchase and sale of prescription drugs in Southeast Asia and Taiwan, as well as the provision and collection of information on products.

Webull offers Sumitomo Pharma Co Ltd stock information, including OTCPK: DNPUF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DNPUF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DNPUF stock methods without spending real money on the virtual paper trading platform.